• Affimed, Genentech Enter Cancer Collaboration contractpharma
    August 30, 2018
    Affimed has entered into a collaboration agreement with Genentech, a member of the Roche Group, to develop and commercialize novel NK cell engager-based immunotherapeutics to treat multiple cancers.
PharmaSources Customer Service